Therapeutic advances in neural regeneration for Huntington's disease
Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions, Htt is involved in many cellular process...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Neural Regeneration Research |
| Subjects: | |
| Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=9;spage=1991;epage=1997;aulast= |
| _version_ | 1797299956468416512 |
|---|---|
| author | Francesco D'Egidio Vanessa Castelli Giorgia Lombardozzi Fabrizio Ammannito Annamaria Cimini Michele d'Angelo |
| author_facet | Francesco D'Egidio Vanessa Castelli Giorgia Lombardozzi Fabrizio Ammannito Annamaria Cimini Michele d'Angelo |
| author_sort | Francesco D'Egidio |
| collection | DOAJ |
| description | Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions, Htt is involved in many cellular processes such as cell signaling, transcriptional regulation, energy metabolism regulation, DNA maintenance, axonal trafficking, and antiapoptotic activity. When the genetic alteration is present, the production of a mutant version of Htt (mHtt) occurs, which is characterized by a plethora of pathogenic activities that, finally, lead to cell death. Among all the cells in which mHtt exerts its dangerous activity, the GABAergic Medium Spiny Neurons seem to be the most affected by the mHtt-induced excitotoxicity both in the cortex and in the striatum. However, as the neurodegeneration proceeds ahead the neuronal loss grows also in other brain areas such as the cerebellum, hypothalamus, thalamus, subthalamic nucleus, globus pallidus, and substantia nigra, determining the variety of symptoms that characterize Huntington's disease. From a clinical point of view, Huntington's disease is characterized by a wide spectrum of symptoms spanning from motor impairment to cognitive disorders and dementia. Huntington's disease shows a prevalence of around 3.92 cases every 100,000 worldwide and an incidence of 0.48 new cases every 100,000/year. To date, there is no available cure for Huntington's disease. Several treatments have been developed so far, aiming to reduce the severity of one or more symptoms to slow down the inexorable decline caused by the disease. In this context, the search for reliable strategies to target the different aspects of Huntington's disease become of the utmost interest. In recent years, a variety of studies demonstrated the detrimental role of neuronal loss in Huntington's disease condition highlighting how the replacement of lost cells would be a reasonable strategy to overcome the neurodegeneration. In this view, numerous have been the attempts in several preclinical models of Huntington's disease to evaluate the feasibility of invasive and non-invasive approaches. Thus, the aim of this review is to offer an overview of the most appealing approaches spanning from stem cell-based cell therapy to extracellular vesicles such as exosomes in light of promoting neurogenesis, discussing the results obtained so far, their limits and the future perspectives regarding the neural regeneration in the context of Huntington's disease. |
| first_indexed | 2024-03-07T22:59:10Z |
| format | Article |
| id | doaj.art-6d3b3d099778440692b6af4e5ac9b1ac |
| institution | Directory Open Access Journal |
| issn | 1673-5374 |
| language | English |
| last_indexed | 2024-03-07T22:59:10Z |
| publishDate | 2024-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Neural Regeneration Research |
| spelling | doaj.art-6d3b3d099778440692b6af4e5ac9b1ac2024-02-22T15:19:04ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742024-01-011991991199710.4103/1673-5374.390969Therapeutic advances in neural regeneration for Huntington's diseaseFrancesco D'EgidioVanessa CastelliGiorgia LombardozziFabrizio AmmannitoAnnamaria CiminiMichele d'AngeloHuntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions, Htt is involved in many cellular processes such as cell signaling, transcriptional regulation, energy metabolism regulation, DNA maintenance, axonal trafficking, and antiapoptotic activity. When the genetic alteration is present, the production of a mutant version of Htt (mHtt) occurs, which is characterized by a plethora of pathogenic activities that, finally, lead to cell death. Among all the cells in which mHtt exerts its dangerous activity, the GABAergic Medium Spiny Neurons seem to be the most affected by the mHtt-induced excitotoxicity both in the cortex and in the striatum. However, as the neurodegeneration proceeds ahead the neuronal loss grows also in other brain areas such as the cerebellum, hypothalamus, thalamus, subthalamic nucleus, globus pallidus, and substantia nigra, determining the variety of symptoms that characterize Huntington's disease. From a clinical point of view, Huntington's disease is characterized by a wide spectrum of symptoms spanning from motor impairment to cognitive disorders and dementia. Huntington's disease shows a prevalence of around 3.92 cases every 100,000 worldwide and an incidence of 0.48 new cases every 100,000/year. To date, there is no available cure for Huntington's disease. Several treatments have been developed so far, aiming to reduce the severity of one or more symptoms to slow down the inexorable decline caused by the disease. In this context, the search for reliable strategies to target the different aspects of Huntington's disease become of the utmost interest. In recent years, a variety of studies demonstrated the detrimental role of neuronal loss in Huntington's disease condition highlighting how the replacement of lost cells would be a reasonable strategy to overcome the neurodegeneration. In this view, numerous have been the attempts in several preclinical models of Huntington's disease to evaluate the feasibility of invasive and non-invasive approaches. Thus, the aim of this review is to offer an overview of the most appealing approaches spanning from stem cell-based cell therapy to extracellular vesicles such as exosomes in light of promoting neurogenesis, discussing the results obtained so far, their limits and the future perspectives regarding the neural regeneration in the context of Huntington's disease.http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=9;spage=1991;epage=1997;aulast=cell therapy; exosomes; extracellular vesicles; huntingtin; huntington's disease; medium spiny neurons; neurodegenerative disease; neurogenesis; neuronal loss; stem cells |
| spellingShingle | Francesco D'Egidio Vanessa Castelli Giorgia Lombardozzi Fabrizio Ammannito Annamaria Cimini Michele d'Angelo Therapeutic advances in neural regeneration for Huntington's disease Neural Regeneration Research cell therapy; exosomes; extracellular vesicles; huntingtin; huntington's disease; medium spiny neurons; neurodegenerative disease; neurogenesis; neuronal loss; stem cells |
| title | Therapeutic advances in neural regeneration for Huntington's disease |
| title_full | Therapeutic advances in neural regeneration for Huntington's disease |
| title_fullStr | Therapeutic advances in neural regeneration for Huntington's disease |
| title_full_unstemmed | Therapeutic advances in neural regeneration for Huntington's disease |
| title_short | Therapeutic advances in neural regeneration for Huntington's disease |
| title_sort | therapeutic advances in neural regeneration for huntington s disease |
| topic | cell therapy; exosomes; extracellular vesicles; huntingtin; huntington's disease; medium spiny neurons; neurodegenerative disease; neurogenesis; neuronal loss; stem cells |
| url | http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=9;spage=1991;epage=1997;aulast= |
| work_keys_str_mv | AT francescodegidio therapeuticadvancesinneuralregenerationforhuntingtonsdisease AT vanessacastelli therapeuticadvancesinneuralregenerationforhuntingtonsdisease AT giorgialombardozzi therapeuticadvancesinneuralregenerationforhuntingtonsdisease AT fabrizioammannito therapeuticadvancesinneuralregenerationforhuntingtonsdisease AT annamariacimini therapeuticadvancesinneuralregenerationforhuntingtonsdisease AT micheledangelo therapeuticadvancesinneuralregenerationforhuntingtonsdisease |